Search

Christopher C. Caillouet

Examiner (ID: 8951, Phone: (571)270-3968 , Office: P/1745 )

Most Active Art Unit
1745
Art Unit(s)
1791, 1745
Total Applications
862
Issued Applications
546
Pending Applications
67
Abandoned Applications
259

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5224917 [patent_doc_number] => 20070254183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Electroluminescent materials and deivces' [patent_app_type] => utility [patent_app_number] => 11/660626 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 4719 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20070254183.pdf [firstpage_image] =>[orig_patent_app_number] => 11660626 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/660626
Electroluminescent materials and deivces Aug 25, 2005 Abandoned
Array ( [id] => 5895462 [patent_doc_number] => 20060004001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors' [patent_app_type] => utility [patent_app_number] => 11/211829 [patent_app_country] => US [patent_app_date] => 2005-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19433 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20060004001.pdf [firstpage_image] =>[orig_patent_app_number] => 11211829 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/211829
Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors Aug 24, 2005 Abandoned
Array ( [id] => 285555 [patent_doc_number] => 07550482 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-23 [patent_title] => 'Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors' [patent_app_type] => utility [patent_app_number] => 11/210569 [patent_app_country] => US [patent_app_date] => 2005-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16006 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/550/07550482.pdf [firstpage_image] =>[orig_patent_app_number] => 11210569 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/210569
Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors Aug 23, 2005 Issued
11/206158 2,6-Quinolinyl derivatives, processes for preparing them and their uses Aug 17, 2005 Abandoned
Array ( [id] => 285671 [patent_doc_number] => 07550598 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-23 [patent_title] => 'Kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/208437 [patent_app_country] => US [patent_app_date] => 2005-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38401 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/550/07550598.pdf [firstpage_image] =>[orig_patent_app_number] => 11208437 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/208437
Kinase inhibitors Aug 17, 2005 Issued
Array ( [id] => 5801536 [patent_doc_number] => 20060035931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Crystalline form of a biphenyl compound' [patent_app_type] => utility [patent_app_number] => 11/204065 [patent_app_country] => US [patent_app_date] => 2005-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 22061 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035931.pdf [firstpage_image] =>[orig_patent_app_number] => 11204065 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/204065
Crystalline form of a biphenyl compound Aug 14, 2005 Issued
Array ( [id] => 311228 [patent_doc_number] => 07528253 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-05 [patent_title] => 'Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity' [patent_app_type] => utility [patent_app_number] => 11/204066 [patent_app_country] => US [patent_app_date] => 2005-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35599 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/528/07528253.pdf [firstpage_image] =>[orig_patent_app_number] => 11204066 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/204066
Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity Aug 14, 2005 Issued
Array ( [id] => 4670477 [patent_doc_number] => 20080045537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Chemical Compounds' [patent_app_type] => utility [patent_app_number] => 11/573729 [patent_app_country] => US [patent_app_date] => 2005-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73036 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045537.pdf [firstpage_image] =>[orig_patent_app_number] => 11573729 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/573729
Chemical Compounds Aug 11, 2005 Abandoned
Array ( [id] => 5801535 [patent_doc_number] => 20060035930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => '4-(2,4-dichloro-5-methoxyphenyl)amino-6-methoxy-7-{[5-substituted -amino)methyl]-3-furyl}-3-quinolinecarbonitriles as kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/201705 [patent_app_country] => US [patent_app_date] => 2005-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11282 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035930.pdf [firstpage_image] =>[orig_patent_app_number] => 11201705 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/201705
4-(2,4-dichloro-5-methoxyphenyl)amino-6-methoxy-7-{[5-substituted-amino)methyl]-3-furyl}-3-quinolinecarbonitriles as kinase inhibitors Aug 10, 2005 Issued
Array ( [id] => 4461664 [patent_doc_number] => 07880006 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-01 [patent_title] => 'Quinoline derivatives and insecticide comprising thereof as active ingredient' [patent_app_type] => utility [patent_app_number] => 11/632420 [patent_app_country] => US [patent_app_date] => 2005-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49931 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/880/07880006.pdf [firstpage_image] =>[orig_patent_app_number] => 11632420 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/632420
Quinoline derivatives and insecticide comprising thereof as active ingredient Aug 2, 2005 Issued
Array ( [id] => 4760048 [patent_doc_number] => 20080312274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Quinoline Derivatives as Neurokinin Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 11/659401 [patent_app_country] => US [patent_app_date] => 2005-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6258 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312274.pdf [firstpage_image] =>[orig_patent_app_number] => 11659401 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/659401
Quinoline Derivatives as Neurokinin Receptor Antagonists Jul 27, 2005 Abandoned
Array ( [id] => 4916284 [patent_doc_number] => 20080096885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'Quinoline Derivatives as Neurokinin Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 11/659399 [patent_app_country] => US [patent_app_date] => 2005-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13012 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20080096885.pdf [firstpage_image] =>[orig_patent_app_number] => 11659399 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/659399
Quinoline Derivatives as Neurokinin Receptor Antagonists Jul 27, 2005 Abandoned
Array ( [id] => 5829204 [patent_doc_number] => 20060063803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => '4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds' [patent_app_type] => utility [patent_app_number] => 11/187854 [patent_app_country] => US [patent_app_date] => 2005-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 44946 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063803.pdf [firstpage_image] =>[orig_patent_app_number] => 11187854 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/187854
4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds Jul 24, 2005 Abandoned
Array ( [id] => 5297192 [patent_doc_number] => 20090012118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Kynurenic Acid Amide Derivatives as Nr2b Receptor Antagoni' [patent_app_type] => utility [patent_app_number] => 11/658690 [patent_app_country] => US [patent_app_date] => 2005-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6226 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20090012118.pdf [firstpage_image] =>[orig_patent_app_number] => 11658690 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/658690
Kynurenic Acid Amide Derivatives as Nr2b Receptor Antagoni Jul 20, 2005 Abandoned
Array ( [id] => 6931846 [patent_doc_number] => 20050282881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/185349 [patent_app_country] => US [patent_app_date] => 2005-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45264 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282881.pdf [firstpage_image] =>[orig_patent_app_number] => 11185349 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/185349
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof Jul 19, 2005 Issued
Array ( [id] => 5608415 [patent_doc_number] => 20060269931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Purine based fluorescent dyes' [patent_app_type] => utility [patent_app_number] => 11/177923 [patent_app_country] => US [patent_app_date] => 2005-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4845 [patent_no_of_claims] => 89 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20060269931.pdf [firstpage_image] =>[orig_patent_app_number] => 11177923 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/177923
Purine based fluorescent dyes Jul 6, 2005 Issued
Array ( [id] => 318850 [patent_doc_number] => 07521560 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-21 [patent_title] => '2-substituted quinoline compounds and their uses' [patent_app_type] => utility [patent_app_number] => 11/171580 [patent_app_country] => US [patent_app_date] => 2005-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18790 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/521/07521560.pdf [firstpage_image] =>[orig_patent_app_number] => 11171580 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/171580
2-substituted quinoline compounds and their uses Jun 28, 2005 Issued
Array ( [id] => 7593060 [patent_doc_number] => 07652141 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-26 [patent_title] => 'Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor' [patent_app_type] => utility [patent_app_number] => 11/168640 [patent_app_country] => US [patent_app_date] => 2005-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 96925 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/652/07652141.pdf [firstpage_image] =>[orig_patent_app_number] => 11168640 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/168640
Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor Jun 28, 2005 Issued
Array ( [id] => 4688804 [patent_doc_number] => 20080032985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => '4-Substituted Quinoline Derivatives, Method and Intermediates for Their Preparation and Pharmaceutical Compositions Containing Them' [patent_app_type] => utility [patent_app_number] => 11/571407 [patent_app_country] => US [patent_app_date] => 2005-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16145 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20080032985.pdf [firstpage_image] =>[orig_patent_app_number] => 11571407 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/571407
4-Substituted Quinoline Derivatives, Method and Intermediates for Their Preparation and Pharmaceutical Compositions Containing Them Jun 23, 2005 Abandoned
Array ( [id] => 348987 [patent_doc_number] => 07495103 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-24 [patent_title] => 'Modulators of ATP-binding cassette transporters' [patent_app_type] => utility [patent_app_number] => 11/165818 [patent_app_country] => US [patent_app_date] => 2005-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 88500 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/495/07495103.pdf [firstpage_image] =>[orig_patent_app_number] => 11165818 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/165818
Modulators of ATP-binding cassette transporters Jun 23, 2005 Issued
Menu